Melinda French Gates is putting another $215 million into women’s health, expanding a campaign she says has become central to the work she does through Pivotal. The new pledge, announced Thursday, will support contraceptive access, maternal care and efforts aimed at middle-aged women, including more study of menopause.
The money lands at a moment when French Gates has already pushed her women’s health giving past $600 million in the past two years. That scale matters because she is no longer operating as a donor on the sidelines: after stepping away from The Gates Foundation in 2024, she has made women’s health one of the clearest lines in her philanthropy.
Her case for the spending is straightforward. Women make up half the population, yet the World Economic Forum says the health issues that specifically affect them get only 2% of private healthcare funds. French Gates said philanthropy should shine a light on problems left behind, show ways to make progress and then bring in other donors and, eventually, government money.
The new pledge also builds on earlier bets that show where she is already leaning. She gave $40 million to Co-Impact for an initiative that embeds mental health support into maternal and primary care, especially in Africa, and $10 million to The Menopause Society to improve menopause care in the United States. Dr. Stephanie Faubion said there are about 6,000 counties in the United States where patients have critically low access to menopause-competent clinicians, a reminder that the gaps are not confined to poorer countries.
That gap is part of the friction around the announcement. Menopause research was already underfunded before recent medical research cuts by President Donald Trump’s administration took effect, and the exact split of the new $215 million has not been disclosed. French Gates is sending a signal that women’s health is fundamental and deserves far more than it has received; the unanswered question is whether this latest pledge can help move other funders toward the same place.
